Faxon, D P <br/><br/>
Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group.  [electronic resource] 

 -  Journal of the American College of Cardiology  Feb 1995 
 - 362-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0735-1097 
<br/><br/><label>Standard No.: </label>10.1016/0735-1097(94)00368-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angioplasty, Balloon, Coronary<br/>Aspirin--therapeutic use<br/>Cilazapril--administration & dosage<br/>Coronary Angiography<br/>Coronary Disease--diagnostic imaging<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Linear Models<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome